everolimus
Not Tagged
['s0931', 'emend', 'rcc,(-irccs),(-srcc),(-urcc)', 'knight']
 s0931 presented at #asco22 by dr. ryan : everolimus vs placebo for adjuvant rcc. 1400 pts, ~400 sites; tremendous scale. everolimus used less frequently in mrcc care now (sometimes paired with lenva in 3+l setting). pts elig w variety of t stage/grade 
Med onc at UW/SCCA/Fred Hutch focused on melanoma and RCC, interested in patient/caregiver QOL and all things immunotherapy. All opinions are my own.